Gentamicin
From Wikipedia, the free encyclopedia
 |
|
 |
|
|
Gentamicin
|
|
| Systematic (IUPAC) name | |
| 2-[4,6-diamino-3- [3-amino-6-(1-methylaminoethyl) tetrahydropyran-2-yl] oxy-2-hydroxy- cyclohexoxy]-5-methyl- 4-methylamino-tetrahydropyran-3,5-diol | |
| Identifiers | |
| CAS number | |
| ATC code | D06 J01GB03, S01AA11, S02AA14, S03AA06 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C21H43N5O7 |
| Mol. mass | 477.596 g/mol |
| Pharmacokinetic data | |
| Bioavailability | limited oral bioavailability |
| Protein binding | 0-10% |
| Metabolism | ? |
| Half life | 2 hrs |
| Excretion | renal |
| Therapeutic considerations | |
| Pregnancy cat. |
D |
| Legal status | |
| Routes | IV/IM |
Gentamicin is an aminoglycoside antibiotic, used to treat many types of bacterial infections, particularly those caused by Gram-negative bacteria. However, gentamicin is not used for Neisseria gonorrhoeae, Neisseria meningitidis or Legionella pneumophila bacterial infections.
It is synthesized by Micromonospora, a genus of Gram-positive bacteria widely present in the environment (water and soil). To highlight their specific biological origins, gentamicin and other related antibiotics produced by this genus (verdamicin, mutamicin, sisomicin, netilmicin, retymicin) have generally their spellings ending in ~micin and not in ~mycin. Gentamicin is a bactericidal antibiotic that works by binding the 30S subunit of the bacterial ribosome, interrupting protein synthesis.
Like all aminoglycosides, when gentamicin is given orally, it is not systemically active. This is because it is not absorbed to any appreciable extent from the small intestine. It appears to be completely eliminated unchanged in the urine. Urine must be collected for many days to recover all of a given dose because the drug binds avidly to certain tissues. It is administered intravenously, intramuscularly or topically to treat infections.
E. coli has shown some resistance to gentamicin, despite being Gram-negative.
Gentamicin is one of the few heat-stable antibiotics that remain active even after autoclaving, which makes it particularly useful in the preparation of certain microbiological growth media.
Treatment of susceptible bacterial infections, normally Gram-negative bacteria including Pseudomonas, Proteus, Serratia, and Gram-positive Staphylococcus. [1]
[edit] Side effects
All aminoglycosides are toxic to the sensory cells of the ear, but they vary greatly in their relative effects on hearing versus balance. Gentamicin is a vestibulotoxin, and can cause permanent loss of equilibrioception, caused by damage to the vestibular apparatus of the inner ear, usually if taken at high doses or for prolonged periods of time, but there are well documented cases in which gentamicin completely destroyed the vestibular apparatus after three to five days. Since the effects of vestibulotoxicity are physically and psychologically devastating, a Web site has been formed to advise people with gentamicin-induced destruction of the balance system: Wobblers Anonymous at http://www.wobblers.com/ Gentamicin can also impair or wholly destroy hearing. A small number of affected individuals have a normally harmless mutation in their mitochondrial RNA, that allows the gentamicin to affect their cells. The cells of the ear are particularly sensitive to this. Gentamicin is sometimes used intentionally for this purpose in severe Ménière's disease, to disable the vestibular apparatus.
Gentamicin can also be highly nephrotoxic, particularly if multiple doses accumulate over a course of treatment. For this reason gentamicin is usually dosed by body weight. Various formulae exist for calculating gentamicin dosage. Also trough and peak serum levels of gentamicin are monitored during treatment, generally before and after the third dose is infused.
Gentamicin, like other aminoglycosides, causes nephrotoxicity by inhibiting protein synthesis in renal cells. This mechanism specifically causes necrosis of cells in the proximal tubule, resulting in acute tubular necrosis which can lead to acute renal failure.[1]
Side effects of gentamicin toxicity vary from patient to patient. Side effects may become apparent shortly after or up to months after gentamicin is administered. Symptoms of gentamicin toxicity are not limited to:
-Balance Difficulty
-Boucing/Unsteady Vision
-Ringing in the ears
-Difficulty multi-tasking particulary standing up
Immediate professional help should be sought if any of these symptoms or other appear after administration of aminoglycosides. General medical practitioners should refer patients with such symptoms to Ear Nose Throat or similar specialists for comprehensive tests.
[edit] Gentamicin producers
Gentamicin is produced by a fermentation procedure. The majority of the world's gentamicin production takes place in China and South Korea; the last European producer is Lek, part of Sandoz group.
[edit] References
- ^ Sundin DP, Sandoval R, Molitoris BA: Gentamicin Inhibits Renal Protein and Phospholipid Metabolism in Rats: Implications Involving Intracellular Trafficking. J Am Soc Nephrol 12:114-123, 2001
Complete Gentamicin Information at Drugs.com
Wobblers.com is a well established Support Group for Gentamicin Victims
|
|||||||||||||||||
|
||||||||
|
|||||||||||
